|
Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer Clinical research trials and Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer. Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer clinical trial. Test subjects typically receive the most effective healthcare possible for their Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "I" Clinical Trials Conditions > Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer  Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer
Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer
For Condition: Prostate Cancer,Lung Cancer,Breast Cancer,Colorectal Cancer
Status: Recruiting
Sponsor(s): Eastern Cooperative Oncology Group , National Cancer Institute (NCI)
Synopsis: RATIONALE: Identification of genes that may be associated with developing certain types of cancer may someday provide important information about a person's risk of getting cancer. PURPOSE: Clinical trial to identify genes that may be associated with cancer in patients and siblings who have cancer of the breast, prostate, lung, or colon.
Details: OBJECTIVES: - Gather allele-sharing statistics at approximately 100 candidate loci throughout the human genome most likely to influence genetic risk of cancer. - Use these allele-sharing statistics to test the interaction of each locus individually with cancer-associated, rare alleles of HRAS1. - Generalize this approach for one of four cancers (breast, colon, lung, or prostate), using allele-sharing statistics to test the interaction of each locus with every other locus. - Replicate positive results in a distinct set of sibling pairs with cancer. - Examine, when loci contributing to risk are detected, the influence of this genetic background on clinical outcomes, such as survival. OUTLINE: Each patient-sibling pair completes a family history questionnaire about the incidence of cancer in the family. Blood samples are obtained from both the patient and the sibling (and both living parents, if available). The blood samples are genotyped using approximately 300 micro-satellite markers flanking 100 candidate genes previously implicated in genetic risk for cancer. Certain loci are a priority due to their association with HRAS1: BRCA1 and all known mismatch repair loci; other repair genes, such as ATM; the Bloom's syndrome locus; and the XRCC group. Other genes are also mapped. Patients do not receive the results of the genetic testing and the results do not influence the type and duration of treatment. Patients only are followed annually. PROJECTED ACCRUAL: This study will accrue 1,000 patient-sibling pairs for breast cancer. After 18 months, another 1,000 patient-sibling pairs will be accrued for breast cancer. Therefore, up to 2,000 patient-sibling pairs will be accrued over 5 years. (Feasibility of accruing pairs for lung, colon, and prostate cancer is being assessed.)
Eligibility:
Study Type: Interventional, Diagnostic
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: DISEASE CHARACTERISTICS: - Histologically confirmed colon, lung, prostate, or invasive breast cancer - No ductal or lobular carcinoma in situ of the breast only - Patient and natural full sibling must have (or have had) cancer of the same type - Participants in E-3Y92 not eligible - Hormone receptor status: - Not specified PATIENT CHARACTERISTICS: Age: - Not specified Menopausal status: - Not specified Performance status: - Not specified Life expectancy: - Not specified Hematopoietic: - Not specified Hepatic: - Not specified Renal: - Not specified PRIOR CONCURRENT THERAPY: Biologic therapy - Not specified Chemotherapy - Not specified Endocrine therapy - Not specified Radiotherapy - Not specified Surgery - Not specified
Total Enrollment:
Location and Contact Information:
Overall Study Official:
TheodoreKrontiris, Study Chair, Beckman Research Institute
CCOP - Southern Nevada Cancer Research Foundation *Recruiting*
Las Vegas, Nevada, 89106
United States
Recruiting John Ellerton 702-384-0013
Albert Einstein Clinical Cancer Center *Recruiting*
Bronx, New York, 10461
United States
Recruiting Joseph Sparano 718-904-2555
CCOP - Scott and White Hospital *Recruiting*
Temple, Texas, 76508
United States
Recruiting Lucas Wong 254-724-7048
Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center *Recruiting*
Nashville, Tennessee, 37232-6307
United States
Recruiting David Johnson 615-343-9454
Veterans Affairs Medical Center - Madison *Recruiting*
Madison, Wisconsin, 53705
United States
Recruiting Mark Albertini 608-262-7017
CCOP - Evanston *Recruiting*
Evanston, Illinois, 60201
United States
Recruiting Gershon Locker 847-570-2518
Hillman Cancer Center at University of Pittsburgh Cancer Institute *Recruiting*
Pittsburgh, Pennsylvania, 15236
United States
Recruiting John Kirkwood 412-692-4724
University of Wisconsin Comprehensive Cancer Center *Recruiting*
Madison, Wisconsin, 53792-0001
United States
Recruiting James Stewart 608-265-8131
City of Hope Comprehensive Cancer Center *Recruiting*
Duarte, California, 91010-3000
United States
Recruiting Theodore Krontiris 626-301-8164
Pretoria Academic Hospital *Recruiting*
Pretoria, , 0001
South Africa
Recruiting Coenraad Slabber 27-12-354-1054
CCOP - St. Vincent Hospital Cancer Center, Green Bay *Recruiting*
Green Bay, Wisconsin, 54307-3453
United States
Recruiting Gerald Bayer 920-433-8889
Additional Information:
Study ID Numbers: CDR0000066283; ECOG-1Y97
Study Start Date:
Record last reviewed: April 1999
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00003329
Other Colorectal Cancer Studies:
1. Conventional Care With or Without Specialized Cancer Care in Treating Patients Receiving Chemotherapy
2. A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy with G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients
3. Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function
4. Vaccination Against Melanoma and Other Cancers
5. The Treatment of Stage I and II Breast Cancer with Mastectomy and Axillary Dissection vs. Excisional Biopsy, Axillary Dissection, and Radiotherapy
Related Studies:
Other Colorectal Cancer Clinical Trials
Other Tennessee Clinical Trials
Other Nashville Clinical Trials
Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer
|
|
|
|
|
|
|
|
